Next-level medicine with ease.

Next-level medicine
with ease.

We are a biotech company that pioneers the discovery and development of previously inaccessible biologics.

Company

Discovering and developing a pipeline of highly differentiated product candidates.

Pipeline

Innovative therapies in early development.

Technology

Expression of complex biologics beyond the reach of conventional production platforms, including recombinant antibody modalities and structurally complex blood proteins. Powered by moss.

Decades of expertise. One purpose. Transforming complex and previously inaccessible biologics into medicines for diseases where innovation can make the difference for patients.

  • Dr. Dénes Zalai
    Director Technology
  • Dr. Christian Abraham, MBA
    Director Strategic Alliances
  • Dr. Erich Rajkovic, PhD, MBA, CBO
    Chief Business Officer
  • Björn Cochlovius, Ph.D., Assoc. Prof.
    Chief Executive Officer & Managing Director
Partnering

Eleva Biologics is an indispensable strategic partner for the discovery and co-development of highly complex biologics that have been impossible or difficult to make on other platforms.

Stay up to date on our progress to learn more about how Eleva Biologics is discovering and developing biologics with highly differentiated competitive product profiles that are difficult or impossible to achieve with other available production systems.

  • May 28, 2025

    ...focuses on Age-related Macular Degeneration (AMD), a chronic retinal disease that primarily affects older adults and represents one of the leading causes of vision loss in aging populations.
News

Stay in the loop and subscribe to our newsletter.

Career

Eleva Biologics offers a workplace that is focused on bringing novel or improved therapies to patients with no or limited treatment options.

Next Page